Roche, Gen-Probe WNV Study Sites Begin Screening Under IND Approval
This article was originally published in The Gray Sheet
Executive Summary
FDA is consulting with the Office of the Chief Counsel regarding potential legal issues related to institutional review board approval of clinical trial sites participating in West Nile Virus IND studies
You may also be interested in...
JAMA Articles Assess Nucleic Acid West Nile Virus Screening Programs
Screening individual blood donations for West Nile Virus in high-prevalence regions using nucleic acid amplification test kits identifies low level infections missed by pooled sample testing, according to two studies in the Journal of the American Medical Association
JAMA Articles Assess Nucleic Acid West Nile Virus Screening Programs
Screening individual blood donations for West Nile Virus in high-prevalence regions using nucleic acid amplification test kits identifies low level infections missed by pooled sample testing, according to two studies in the Journal of the American Medical Association
West Nile Virus Assay Makers Race To Meet FDA’s Testing Needs By Summer
Focus Technologies expects to be the first company to offer a West Nile Virus clinical diagnostic in the U.S